Xeomin and Panic attack - a phase IV clinical study of FDA data

Summary:

Panic attack is reported as a side effect among people who take Xeomin (incobotulinumtoxina), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Botox, and have Skin wrinkling.

The phase IV clinical study analyzes which people have Panic attack when taking Xeomin. It is created by eHealthMe based on reports of 4,233 people who have side effects when taking Xeomin from the FDA, and is updated regularly.

What is Xeomin?

Xeomin has active ingredients of incobotulinumtoxina. eHealthMe is studying from 4,239 Xeomin users. Check the latest studies of Xeomin.

What is Panic attack?

Panic attack is found to be associated with 2,326 drugs and 2,081 conditions by eHealthMe. Check the latest studies of Panic attack.



On Jun, 26, 2026

4,233 people reported to have side effects when taking Xeomin.
Among them, 10 people (0.24%) have Panic attack.

Could Xeomin cause Panic attack?

Among these 10 people:

How long have people been on Xeomin when they have Panic attack? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Panic attack when taking Xeomin? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Panic attack when taking Xeomin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 55.56 %
  • 40-49: 44.44 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Xeomin? *

  1. Botox: 2 people, 20.00%
  2. Zyrtec: 1 person, 10.00%
  3. Morphine: 1 person, 10.00%
  4. Lyrica: 1 person, 10.00%
  5. Gabapentin: 1 person, 10.00%
  6. Buspar: 1 person, 10.00%
  7. Baclofen: 1 person, 10.00%
  8. Amitiza: 1 person, 10.00%

What are other side effects people have besides Panic attack? *

  1. Dizziness: 5 people, 50.00%
  2. Headache (pain in head): 5 people, 50.00%
  3. Vision Blurred: 4 people, 40.00%
  4. Stress And Anxiety: 4 people, 40.00%
  5. Diplopia (double vision): 2 people, 20.00%
  6. Weakness: 2 people, 20.00%
  7. Migraine (headache): 2 people, 20.00%
  8. Muscle Atrophy (a decrease in the mass of the muscle): 2 people, 20.00%
  9. Hair Loss: 2 people, 20.00%
  10. Feeling Abnormal: 2 people, 20.00%

What are the existing conditions these people have? *

  1. Skin Wrinkling (wrinkle on skin): 5 people, 50.00%
  2. Torticollis (a twisted neck in which the head is tipped to one side, while the chin is turned to the other): 1 person, 10.00%
  3. Bruxism (habitual grinding of the teeth, typically during sleep): 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Xeomin and have Panic attack?

- Check whether Panic attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xeomin:

Panic attack treatments and more:

How severe was Panic attack and when was it recovered:

Expand to all the drugs that have ingredients of incobotulinumtoxina:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xeomin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attack:

Browse all the conditions that are associated with Panic attack:


How the study uses the data?

The study uses data from the FDA. It is based on incobotulinumtoxina (the active ingredients of Xeomin) and Xeomin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: